In CRC, MEF2A promotes tumour progression by upregulating ZEB2 (Zinc Finger E‐Box Binding Homeobox 2) and CTNNB1 (Catenin Beta 1).31 The gene discussed is MEF2A; the disease is colorectal carcinoma.